GOLDENWELL BIOTECH, INC. (GWLL)
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Sector: Food and Kindred Products
Industry: Medical - Pharmaceuticals
Goldenwell Biotech, Inc.
OTC:GWLLHealthcare · Medical - Pharmaceuticals
Mkt Cap$64.35M
Float2.15M
O/S99M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$55
Net Income-$296K
Total Assets$36K
Free Cash Flow-$23K
Debt & Equity
Total Debt$96K
Total Equity-$344K
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in GWLL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$36K
Liabilities$380K
Accounts Receivable$0
Accounts Payable$0
Inventory$175K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $55 | $139 | $2K | $48K | $16K | $0 | $0 |
| YoY Growth | -60.4% | -94.1% | -95.1% | 199.4% | - | - | - |
| Cost of Revenue | $43 | $75 | $1K | $23K | $8K | $0 | $0 |
| Gross Profit | $12 | $64 | $1K | $25K | $8K | $0 | $0 |
| Gross Margin | 21.8% | 46.0% | 47.4% | 52.7% | 52.5% | - | - |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $113K | $123K | $118K | $1.01M | $127K | $6K | $8K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $113K | $123K | $118K | $1.01M | $127K | $6K | $7K |
| Operating Income (EBIT) | -$113K | -$123K | -$117K | -$985K | -$118K | -$6K | -$8K |
| Operating Margin | -206047.3% | -88559.7% | -4995.5% | -2060.9% | -740.7% | - | - |
| Interest Expense | $8K | $8K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$183K | -$8K | $0 | $8 | $1K | $44 | $870 |
| Income Before Tax (EBT) | -$296K | -$131K | -$117K | -$985K | -$117K | -$6K | -$7K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$296K | -$131K | -$117K | -$985K | -$117K | -$6K | -$7K |
| Net Income Margin | -539038.2% | -94602.9% | -4995.5% | -2060.9% | -732.6% | - | - |
| Supplementary Data | |||||||
| EPS | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Weighted Average OS | 99.00M | 99.00M | 96.43M | 96.43M | 91.32M | 96.00M | 76.19M |
| EBITDA | -$113K | -$123K | -$1K | $0 | $0 | $40 | $0 |
| EBITDA Margin | -206047.3% | -88559.7% | -45.7% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $27K | $49K | $53K | $46K | $214K | $249K | $247K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $27K | $49K | $53K | $46K | $214K | $249K | $247K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $175K | $175K | $175K | $176K | $199K | $0 | $0 |
| Other Current Assets | $0 | $0 | -$38 | $0 | $0 | $0 | $0 |
| Total Current Assets | $202K | $224K | $228K | $222K | $412K | $249K | $247K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $26K | $49K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | -$165K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | -$165K | $0 | $0 | $26K | $49K | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $36K | $224K | $228K | $248K | $461K | $249K | $247K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $0 | $0 | $0 | $0 | $111K | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $2K | $2K | $2K | $1K | $0 | $0 | $0 |
| Other Current Liabilities | $100K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $102K | $2K | $2K | $27K | $159K | $0 | $0 |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $96K | $96K | $142K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $182K | $174K | $0 | $20K | -$2 | $0 | $0 |
| Total Long-Term Liabilities | $278K | $270K | $142K | $20K | -$2 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $380K | $271K | $143K | $47K | $159K | $0 | $0 |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $9K | $8K |
| Retained Earnings | -$1.66M | -$1.36M | -$1.23M | -$1.11M | -$126K | -$9K | -$2K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | -$78K | -$8K |
| Other Stockholders' Equity | $1.3M | $1.3M | $1.3M | $1.3M | $418K | $248K | $241K |
| Total Equity | -$344K | -$47K | $85K | $202K | $302K | $249K | $247K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $36K | $224K | $228K | $248K | $461K | $249K | $247K |
| Supplementary Data | |||||||
| Total Debt | $96K | $96K | $142K | $25K | $48K | $0 | $0 |
| Net Debt | $69K | $46K | $89K | -$21K | -$166K | -$249K | -$247K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$296K | -$131K | -$117K | -$985K | -$117K | -$6K | -$7K |
| Depreciation & Amortization | $0 | $0 | $116K | $985K | $118K | $6K | $8K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $175K | $75 | $1K | $23K | -$199K | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | -$111K | $111K | $0 | $0 |
| Other Working Capital | $91K | -$54 | $974 | $1K | -$974 | $0 | $0 |
| Total Working Capital Change | $265K | $21 | $2K | -$87K | -$88K | $0 | $0 |
| Other Non-Cash Items | $8K | $8K | -$116K | -$985K | -$118K | -$6K | -$8K |
| Net Cash from Operating | -$23K | -$123K | -$115K | -$1.07M | -$205K | -$6K | -$7K |
| Investing Activities | |||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | -$119K | -$122K | -$20K | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $885K | $92K | $8K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $885K | $78K | $0 | $747K |
| Net Cash from Financing | $0 | $119K | $122K | $905K | $170K | $8K | $747K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$23K | -$4K | $7K | -$168K | -$35K | $2K | $740K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$23K | -$123K | -$115K | -$1.07M | -$205K | -$6K | -$7K |
| Capital Expenditure | $0 | -$3 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$23K | -$123K | -$115K | -$1.07M | -$205K | -$6K | -$7K |
| Cash at Beginning | $49K | $53K | $46K | $214K | $249K | $247K | $0 |
| Cash at End | $27K | $49K | $53K | $46K | $214K | $249K | $740K |